Synthesis of 2(S)-benzyl-3-[hydroxy(1'(R)-amino ethyl)phosphinyl]propanoyl-L3-[125I]-iodotyrosine: A radiolabelled inhibitor of aminopeptidase N

被引：0
|
作者：
Chen, Huixiong [1 ]
Bischoff, Laurent [1 ]
Fournie-Zaluski, Marie-Claude [1 ]
Roques, Bernard P. [1 ]
机构：
[1] Departement Pharmacochimie Molec. S., INSERM U266, UFR Sci. Pharmaceutiques Biologiques, 4, avenue de l'Observatoire, 75270 Paris Cedex 06, France
来源：
Journal of Labelled Compounds and Radiopharmaceuticals | 2000年 / 43卷 / 02期
关键词：
125I - Amino peptidase - Aminopeptidase N - Biochemical properties - In-vivo - Inhibitor - Pharmacological properties - Phosphinic compound - Radiochemical purity - Specific activity;
D O I：
10.1002/(SICI)1099-1344(200002)43:23.0.CO;2-I
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：103 / 111
相关论文
共 50 条
  • [1] Synthesis of 2(S)-benzyl-3-[hydroxy(1′(R)-amino ethyl)phosphinyl]propanoyl-L-3-[125I]-iodotyrosine:: A radiolabelled inhibitor of aminopeptidase N
    Chen, HX
    Bischoff, L
    Fournie-Zaluski, MC
    Roques, BP
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2000, 43 (02): : 103 - 111
  • [2] Synthesis of [3(R)-amino-2(S)-sulfhydryl-5-sulfonate]-pentanoyl-(S)-3-[125I]-iodotyrosyl-(S)-aspartic acid:: a radiolabelled inhibitor of aminopeptidase A
    David-Basei, C
    Bischoff, L
    Fournie-Zaluski, MC
    Roques, BP
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2001, 44 (01): : 89 - 98
  • [3] Synthesis of (3R)-amino-(2S)-hydroxy amino acids for inhibition of methionine aminopeptidase-1
    Keding, SJ
    Dales, NA
    Lim, SJ
    Beaulieu, D
    Rich, DH
    SYNTHETIC COMMUNICATIONS, 1998, 28 (23) : 4463 - 4470
  • [4] Synthesis of N,N-didemethylzolpidem-N-{2-{3-(4-hydroxy-3-[125I] iodophenyl)}methyl propionate} for use in radioimmunoassay
    De Clerck, I.
    Daenens, P.
    Journal of Labelled Compounds and Radiopharmaceuticals, 1997, 39 (03): : 195 - 203
  • [5] SYNTHESIS AND IN VIVO EVALUATION OF 2-{3-[1-CARBOXY-2-(4-[125I]IODO-BENZYLSULFANYL)-ETHYL]-UREIDO}-PENTANEDIOIC ACID ([125I]DCIBC)
    Dusich, C. L.
    Chen, Y.
    Pullambhatla, M.
    Nimmagadda, S.
    Foss, C. A.
    Fox, J. J.
    Castanares, M.
    Mease, R. C.
    Pomper, M. G.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S18 - S18
  • [6] 3-[125I]iodo-N-[2-(1′-piperidinyl)ethyl]-N-methyl-4-methoxybenzenesulfonamide, 3-[125I]PMS:: A new sigma receptor binding tumor imaging agent.
    John, CS
    Lim, BB
    Geyer, BC
    Vilner, BJ
    Bowen, WD
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 120P - 120P
  • [7] Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1′-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer
    John, CS
    Bowen, WD
    Fisher, SJ
    Lim, BB
    Geyer, BC
    Vilner, BJ
    Wahl, RL
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (04) : 377 - 382
  • [8] Stereoselective synthesis of (3S,4S)-tert-butyl-N-boc-3-ethyl-4-hydroxy-L-prolinate and (3S,4R)-tert-butyl-N-boc-3-ethyl-4-hydroxy-L-prolinate
    Chabaud, P
    Pèpe, G
    Courcambeck, J
    Camplo, M
    TETRAHEDRON, 2005, 61 (15) : 3725 - 3731
  • [9] Synthesis and crystal structure of (R, 4R)-3-[(N-benzyl-N-hydroxy-amino)-(1H-indol-3-yl)-methyl]-oxazolidin-2-one
    David, M
    Denis, JN
    Philouze, C
    Durif, A
    Vallée, Y
    COMPTES RENDUS CHIMIE, 2004, 7 (01) : 41 - 44
  • [10] Preclinical evaluation of 3-[125I]iodo-N-[2-(1I-piperidinyl)ethyl]-4-methoxybenzamide, P[125I]MBA, for imaging breast cancer.
    John, CS
    Fisher, SJ
    Lim, BB
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 100P - 100P
12345